Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 3

Peripheral blood soluble elastin and elastase as auxiliary diagnostic indicators for coronary artery ectasia

Pages
1058–1064
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Circulating s-elastin and elastase are promising biomarkers for assisting in CAE diagnosis.Key words: Coronary artery ectasia, soluble elastin, elastase, biomarker

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Damage to elastin fibres in coronary media might lead to coronary artery ectasia (CAE).
📊
Key Findings & Data:Materials and methods: Fifty-eight patients with CAE, 58 with coronary heart disease (CHD) and 61 with relatively normal coronary arteries, were included.
💡
Conclusion & Impact:Conclusion: Circulating s-elastin and elastase are promising biomarkers for assisting in CAE diagnosis.Key words: Coronary artery ectasia, soluble elastin, elastase, biomarker
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Damage to elastin fibres in coronary media might lead to coronary artery ectasia (CAE). This study evaluated whether CAE can be distinguished by detecting circulating soluble elastin (s-elastin), which is a degradation product of elastin fibres, and elastase, which is the main enzyme of elastin fibres. Materials and methods: Fifty-eight patients with CAE, 58 with coronary heart disease (CHD) and 61 with relatively normal coronary arteries, were included. Circulating s-elastin and elastase were measured, and receiver operating characteristic curves were used to demonstrate their respective optimal cut-off values for predicting CAE. Results: The concentrations of s-elastin and elastase were higher in the CAE group than in the CHD and relatively-normal-coronary groups. Their cut-off values for screening of CAE were 13.148 ng/mL and 25.549 ng/mL, respectively; for sensitivity of CAE were 0.690 and 0.773, respectively; and for specificity of CAE were 0.862 and 0.571, respectively. A combination of s-elastin and elastase in series (one of the two higher than its cut-off value) had a better sensitivity for screening for CAE, whereas their combination in parallel (both higher than their cut-off values) had a better specificity. Conclusion: Circulating s-elastin and elastase are promising biomarkers for assisting in CAE diagnosis.Key words: Coronary artery ectasia, soluble elastin, elastase, biomarker

🔖

Cite This Article

LIANG, S., ZHAO, H., LIU, R., SHENG, Q. (2022). Peripheral blood soluble elastin and elastase as auxiliary diagnostic indicators for coronary artery ectasia. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1058–1064. https://ajindex.com/articles/609886

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sultana R, Sultana N, Ishaq M, Samad A. The prevalence and clinical profile of angiographic coronary ectasia. The Journal of the Pakistan Medical Association 2011
  2. 61 (4): 372-375 2. Devabhaktuni S, Mercedes A, Diep J, Ahsan C. Coronary artery ectasia-a review of current literature. Current Cardiology Reviews 2016
  3. 12 (4): 318-323. doi: 10.2174/1573403x126661 60504100159 3. Valente S, Lazzeri C, Giglioli C, Sani F, Romano SM et al. Clinical expression of coronary artery ectasia. Journal of Cardiovascular Medicine 2007
  4. 8 (10): 815-820. doi: 10.2459/ JCM.0b013e3280115667 4. Liu R, Chen L, Wu W, Chen H, Zhang S. Extracellular matrix turnover in coronary artery ectasia patients. Heart Vessels 2016
  5. 31 (3): 351-359. doi: 10.1007/s00380-014-0622-4 5. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV et al. Clinical significance of coronary arterial ectasia. The American Journal of Cardiology 1976
  6. 37 (2): 217-222. doi: 10.1016/0002- 9149(76)90315-5 6. Korkmaz B, Horwitz MS, Jenne DE, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacological Reviews 2010
  7. 62 (4): 726- 759. doi: 10.1124/pr.110.002733 7. Ammar W, Kappary M, Baghdady Y, Shehata M. Matrix metalloproteinase-9 (MMP9) and high sensitivity c- reactive protein (hs-CRP) in coronary artery ectasia. The Egyptian Heart Journal 2014
  8. doi: 10.1016/j.ehj.2013.04.003 8. Groutas WC, Dou D, Alliston KR. Neutrophil elastase inhibitors. Expert Opinion on Therapeutic Patents 2011
  9. 21 (3): 339- 354. doi: 10.1517/13543776.2011.551115 9. Kawabata K, Hagio T, Matsuoka S. The role of neutrophil elastase in acute lung injury. European Journal of Pharmacology 2002
  10. 451 (1): 1-10. doi: 10.1016/s0014-2999(02)02182-9 10. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV et al. Clinical significance of coronary arterial ectasia. The American Journal of Cardiology 1976
  11. 37 (2): 217-222. doi: 10.1016/0002- 9149(76)90315-5 11. Heiniger PS, Holy EW, Maier W, Nietlispach F, Ruschitzka F et al. Therapeutic strategies in patients with stable coronary artery disease: the role of coronary revascularization. Praxis (Bern 1994) 2019
  12. 108 (6): 401-409. doi: 10.1024/1661-8157/ a003216 12. Robert L, Robert AM, Fulop T. Rapid increase in human life expectancy: will it soon be limited by the aging of elastin? Biogerontology 2008
  13. 9 (2): 119-133. doi: 10.1007/s10522-007- 9122-6 13. Shinohara T, Suzuki K, Okada M, Shiigai M, Shimizu M et al. Soluble elastin fragments